We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA May Reinstate Oversight Policy as Warning Letter Quality Declines
FDA May Reinstate Oversight Policy as Warning Letter Quality Declines
July 9, 2010
Since FDA Commissioner Margaret Hamburg ended prior legal review of warning letters last summer, their quality has declined, industry says, prompting the agency to evaluate the policy change.